title: Ethosuximide and bicuculline inhibition in petit mal epilepsy.
abstract: The mechanisms of petit mal epilepsy remain a mystery despite successful therapy. Previous workers have proposed that paroxysmal activity of cortical inhibitory systems plays a role in absence seizures. In this study, we have compared the effects of bicuculline, a potent convulsive agent and GABA antagonist, with ethosuximide, a drug used to treat petit mal epilepsy, on the thalamocortical motor system of the cat. Under chloralose anesthesia, sequential pairs of pulses were delivered to ventrolateral thalamus (VL) varying either pulse amplitude or interval. The evoked responses were recorded from sensorimotor cortex, analyzed on-line by computer, and plotted as an excitability curve (mean response amplitude as a function of pulse interval), or a family of threshold curves (mean response amplitude as a function of stimulus amplitude at various fixed intervals). Administration of each drug resulted in increased thalamocortical excitability and decreased threshold to stimulation for short pulse-pair intervals, with diminished duration of the excitability curve. Increased alertness was produced by both drugs. Studies with grand mal anticonvulsants demonstrated entirely different effects. Because GABA is thought to be the primary inhibitory transmitter in VL and cerebral cortex, bicuculline would be expected to result in disinhibition. The similarity of the data for ethosuximide suggests that ethosuximide also suppresses inhibition in the thalamocortical motor system and adds further to the accumulating evidence of the role of inhibitory system in petit mal epilepsy.
mesh_terms: D000818:Animals; D001640:Bicuculline / Q000494:pharmacology / Q000627:therapeutic use*; D002415:Cats; D002986:Clinical Trials as Topic; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005013:Ethosuximide / Q000494:pharmacology / Q000627:therapeutic use*; D005071:Evoked Potentials / Q000187:drug effects; D018756:GABA Antagonists; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D009044:Motor Cortex / Q000187:drug effects*; D013788:Thalamus / Q000187:drug effects
chemical_list: D018756:GABA Antagonists; D007546:Isoquinolines; D005013:Ethosuximide; D001640:Bicuculline